Early and simultaneous emergence of multiple hippocampal biomarkers of aging is mediated by Ca2+-induced Ca2+ release

Department of Molecular & Biomedical Pharmacology, University of Kentucky, Lexington, Kentucky, United States
The Journal of Neuroscience : The Official Journal of the Society for Neuroscience (Impact Factor: 6.75). 04/2006; 26(13):3482-90. DOI: 10.1523/JNEUROSCI.4171-05.2006
Source: PubMed

ABSTRACT Age-dependent changes in multiple Ca2+-related electrophysiological processes in the hippocampus appear to be consistent biomarkers of aging, and several also correlate with cognitive decline. These findings have led to the hypothesis that a common mechanism of Ca2+ dyshomeostasis underlies aspects of aging-dependent brain impairment. However, some key predictions of this view remain untested, including that multiple Ca2+-related biomarkers should emerge concurrently during aging and their onset should also precede/coincide with initial signs of cognitive decline. Moreover, blocking a putative common source of dysregulated Ca2+ should eliminate aging differences. Here, we tested these predictions using combined electrophysiological, imaging, and pharmacological approaches in CA1 neurons to determine the ages of onset (across 4-, 10-, 12-, 14-, and 23-month-old F344 rats) of several established biomarkers, including the increases in the slow afterhyperpolarization, spike accommodation, and [Ca2+]i rise during repetitive synaptic stimulation. In addition, we tested the hypothesis that altered Ca2+-induced Ca2+ release (CICR) from ryanodine receptors, which can be triggered by L-type Ca2+ channels, provides a common source of dysregulated Ca2+ in aging. Results showed that multiple aging biomarkers were first detectable at about the same age (12 months of age; approximately midlife), sufficiently early to influence initial cognitive decline. Furthermore, selectively blocking CICR with ryanodine slowed the Ca2+ rise during synaptic stimulation more in aged rat neurons and, notably, reduced or eliminated aging differences in the biomarkers. Thus, this study provides the first evidence that altered CICR plays a role in driving the early and simultaneous emergence in hippocampus of multiple Ca2+-related biomarkers of aging.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Dysregulation of intracellular calcium is associated with increased age and may be linked to cognitive dysfunction syndrome in dogs. This study examined the effectiveness of apoaequorin, a calcium buffering protein, in modifying cognitive decline in aged beagle dogs in two separate studies. In the first study, 23 aged beagle dogs were separated into groups treated with either a placebo, 2.5mg or 5mg doses and were assessed on discrimination learning, attention and visuospatial memory tasks. The apoaequorin treated animals showed improved performance on both the discrimination learning and attention tasks but did not differ from the controls on the spatial memory task. In a second study, we compared 24 dogs treated with either a 5mg or 10mg dose of apoaequorin or with 1 mg/kg selegiline (Anipryl®) an approved treatment for cognitive dysfunction. The group administered 10mg apoaequorin showed superior performance to the animals administered selegiline on both tasks. These results, suggest the calcium binding protein apoaequorin may have beneficial effects in treating cognitive dysfunction in aged beagle dogs and that apoaequorin is at least as beneficial as selegiline.
    Journal of Veterinary Behavior Clinical Applications and Research 02/2015; 10(3). DOI:10.1016/j.jveb.2015.02.003 · 1.22 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Several studies using vertebrate and invertebrate animal models have shown aging associated changes in brain function. Importantly, changes in soma size, loss or regression of dendrites and dendritic spines and alterations in the expression of neurotransmitter receptors in specific neurons were described. Despite this understanding, how aging impacts intrinsic properties of individual neurons or circuits that govern a defined behavior is yet to be determined. Here we discuss current understanding of specific electrophysiological changes in individual neurons and circuits during aging.
    Frontiers in Aging Neuroscience 02/2015; 6. DOI:10.3389/fnagi.2014.00337 · 2.84 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Peripheral insulin resistance is a key component of metabolic syndrome associated with obesity, dyslipidemia, hypertension, and type 2 diabetes. While the impact of insulin resistance is well recognized in the periphery, it is also becoming apparent in the brain. Recent studies suggest that insulin resistance may be a factor in brain aging and Alzheimer's disease (AD) whereby intranasal insulin therapy, which delivers insulin to the brain, improves cognition and memory in AD patients. Here, we tested a clinically relevant delivery method to determine the impact of two forms of insulin, short-acting insulin lispro (Humalog) or long-acting insulin detemir (Levemir), on cognitive functions in aged F344 rats. We also explored insulin effects on the Ca(2+)-dependent hippocampal afterhyperpolarization (AHP), a well-characterized neurophysiological marker of aging which is increased in the aged, memory impaired animal. Low-dose intranasal insulin improved memory recall in aged animals such that their performance was similar to that seen in younger animals. Further, because ex vivo insulin also reduced the AHP, our results suggest that the AHP may be a novel cellular target of insulin in the brain, and improved cognitive performance following intranasal insulin therapy may be the result of insulin actions on the AHP. © The Author 2015. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail:
    The Journals of Gerontology Series A Biological Sciences and Medical Sciences 02/2015; DOI:10.1093/gerona/glu314 · 4.98 Impact Factor